Methotrexate Pfizer Italia (Methotrexate Sodium)

Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for converting folate to its active form. This inhibition reduces the synthesis of DNA, RNA and proteins, particularly in rapidly dividing cells. The drug also increases extracellular adenosine, a molecule that dampens inflammatory pathways, contributing to its immunomodulatory effect.

The dosage of Methotrexate Pfizer Italia is individualized by the prescribing clinician based on the specific indication, patient characteristics and laboratory monitoring. Physicians determine the appropriate strength, frequency and duration, and adjustments are made according to therapeutic response and safety parameters.

Methotrexate is classified as contraindicated in pregnancy because it can cause fetal malformations and miscarriage. Women of childbearing potential must use reliable contraception before, during and after treatment. Limited data exist for breastfeeding, and the drug is generally avoided due to potential infant exposure through milk.

To request Methotrexate Pfizer Italia, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and the necessary import documentation.

Methotrexate is a conventional disease‑modifying antirheumatic drug (DMARD) that is less expensive than many biologic agents and has a well‑established efficacy profile. Compared with newer targeted therapies, it offers oral administration but requires more intensive laboratory monitoring. In oncology, it is one of several antimetabolites and is often combined with other agents to achieve synergistic effects.

Methotrexate Pfizer Italia should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children. Do not refrigerate or freeze the product unless the label specifically indicates a different requirement.

The product is taken orally, usually with a full glass of water. Depending on the prescribing regimen, it may be taken with or without food, but patients should follow the specific instructions given by their healthcare provider. Swallow tablets whole; do not crush or chew unless directed by a clinician.

The most serious adverse events include severe liver toxicity, bone marrow suppression leading to pancytopenia, and pulmonary complications such as interstitial pneumonitis. These risks require regular monitoring of liver enzymes, complete blood counts and respiratory symptoms. Prompt medical attention is essential if any serious signs develop.

Methotrexate is contraindicated in patients with known hypersensitivity to the drug, active severe liver disease, significant renal impairment, uncontrolled infections, and in women who are pregnant or planning pregnancy without effective contraception. Caution is also advised for individuals with a history of pulmonary disease or alcohol misuse.